https://www.milicic-group.net/items/protocol-for-precision-cutting-and-short-term-culture-of-lymph-node-tissue-slices-for-modeling-of-innate-immune-responses-ex-vivo 2026-03-27 https://www.milicic-group.net/items/adjuvanting-a-viral-vectored-vaccine-against-pre-erythrocytic-malaria 2025-06-26 https://www.milicic-group.net/items/technological-approaches-for-improving-vaccination-compliance-and-coverage 2025-06-26 https://www.milicic-group.net/items/tlr-agonists-as-vaccine-adjuvants-targeting-cancer-and-infectious-diseases 2025-06-26 https://www.milicic-group.net/items/inflammasome-mediated-immunogenicity-of-clinical-and-experimental-vaccine-adjuvants 2025-06-26 https://www.milicic-group.net/items/milicic-group-emulsion-and-liposome-based-adjuvanted-r21-vaccine 2025-06-26 https://www.milicic-group.net/items/milicic-group-ex-vivo-model-of-functioning-human-lymph-node 2025-07-30 https://www.milicic-group.net/items/milicic-group-core-shell-microcapsules 2025-07-16